Request Your Free eGuide Now:

"Digital Guide to Commercializing Complex Therapeutics"

New commercial models and resources address unique challenges associated with commercializing complex therapies.

Pharmaceutical manufacturers specializing in Rare Disease, Oncology, Personalized Cancer Immunotherapy, and Cell and Gene therapies encounter a range of complex challenges, including advancements in medicine and technology, changing patient and provider needs, market access, regulatory pathways, pricing transparency, patient reach, patient adherence, and ever evolving disease states. Despite spending over $200 million on product launches, 66% of products fail to meet expectations. Traditional commercialization approaches are no longer effective in these fields.

This user-friendly digital guide aims to assist in navigating the challenges associated with commercializing complex therapies. Below is a directory of the guide’s contents, which link to additional supportive materials:

• Chapter One: Establish Solid Foundational Support for Complex Therapies with a Singular, Proficient Commercialization Model
• Chapter Two: Unlocking Patient-centric Insights to Transform Patient Journeys from Start to Finish
• Chapter Three: Strategic Pricing and Reporting Precision: Achieving Optimal ROI and Patient Access with Delicate Knowledge and Copay Program Management
• Chapter Four: Customized Solutions for Maximum Outputs

Download the digital guide now.

Offered Free by: EVERSANA
See All Resources from: EVERSANA